Background: Little is known about recurrent tuberculosis (TB) among HIV-infected patients and the influence of highly active antiretroviral therapy (HAART). Methods: A population-based retrospective longitudinal study was conducted on all HIV-infected TB patients in Barcelona (Spain) notified in 1987-2003, and followed up until 2005. TB recurrence and HAART influence were analysed according to calendar period. Results: Patients with no-treatment and those in pre-HAART had more risk of TB recurrence (RR: 2.3; CI: 1-5.8 and RR: 4.8; CI: 2-12). Conclusions: HAART decreases probability of TB recurrence and should be extended to all cases.
- Highly active antiretroviral therapy
- Human immunodeficiency virus
ASJC Scopus subject areas
- Microbiology (medical)